OpenBilldrug price receipt

NADAC week of 2026-10-14

KLOR-CON M15 TABLET

FDA nonproprietary name: potassium chloride

For 30 tablets

Pharmacies pay

$14.88 filed

30 × $0.49604 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$22.11 estimated

$14.88 + $2.23 (15%) + $5.00 fee per fill = $22.11

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

KLOR-CON M15 TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as potassium chloride, under the trade name “KLOR-CON M”.

FDA gives its dosage form as tablet, extended release and its route as oral.

The labeler, the company named on the label, is Upsher-Smith Laboratories, LLC.

FDA lists it under 2 Established Pharmacologic Classes: Osmotic Laxative and Potassium Salt.

The NADAC file of 2026-10-14 prices it under 3 NDCs (National Drug Codes); the FDA directory lists 2 of them.

NADAC classes it in its brand rate-setting class B-ANDA, and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $14.88 for 30 tablets (30 × $0.49604 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

All 3 NDCs

Other strengths, forms and brands

14 other products in the NADAC file share the FDA nonproprietary name potassium chloride with KLOR-CON M15 TABLET.

ProductPharmacies pay per unitMedicare per unit
KLOR-CON 8 MEQ TABLET
brand · tablet, film coated, extended release
$0.11807 per EA filed
eff. 2026-08-19
We don’t know yet
KLOR-CON 10 MEQ TABLET
brand · tablet, film coated, extended release
$0.12092 per EA filed
eff. 2026-09-23
We don’t know yet
KLOR-CON 20 MEQ PACKET
brand · powder, for solution
$0.47003 per EA filed
eff. 2026-09-23
We don’t know yet
KLOR-CON M10 TABLET
brand · tablet, extended release
$0.13269 per EA filed
eff. 2026-09-23
We don’t know yet
KLOR-CON M15 TABLET this page
brand · tablet, extended release
$0.49604 per EA filed
eff. 2026-09-23
We don’t know yet
KLOR-CON M20 TABLET
brand · tablet, extended release
$0.14218 per EA filed
eff. 2026-09-23
We don’t know yet
POKONZA 10 MEQ PACKET
brand · powder, for solution
$28.26208 per EA filed
eff. 2026-09-23
We don’t know yet
POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID
generic · solution
$0.04085 per ML filed
eff. 2026-09-23
We don’t know yet
POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID
generic · solution
$0.07285 per ML filed
eff. 2026-09-23
We don’t know yet
POTASSIUM CL 20 MEQ PACKET
generic · powder, for solution / for solution
$0.62416 per EA filed
eff. 2026-09-23
$0.24357 per EA filed
Part D 2024 average
POTASSIUM CL ER 8 MEQ CAPSULE
generic · capsule, extended release
$0.09981 per EA filed
eff. 2026-09-23
We don’t know yet
POTASSIUM CL ER 8 MEQ TABLET
generic · tablet, film coated, extended release / tablet, extended release
$0.10279 per EA filed
eff. 2026-09-23
We don’t know yet
POTASSIUM CL ER 10 MEQ CAPSULE
generic · capsule, extended release
$0.13741 per EA filed
eff. 2026-09-23
We don’t know yet
POTASSIUM CL ER 10 MEQ TABLET
generic · tablet, film coated, extended release / tablet, extended release / tablet
$0.0828 to $0.12716 per EA filed
eff. 2026-09-23
We don’t know yet
POTASSIUM CL ER 20 MEQ TABLET
generic · tablet, extended release / tablet / tablet, film coated, extended release
$0.14078 to $0.18593 per EA filed
eff. 2026-09-23
We don’t know yet

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-08-19, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 3 NDCs’ NADAC prices is $0.49604 per EA filed.

Of the 43 other products in FDA’s Osmotic Laxative class priced per EA, 22 have a higher middle NADAC price and 21 a lower one. The one in the middle is EFFER-K 20 MEQ TABLET EFF, at $0.523 per EA filed (eff. 2026-09-23).

Of the 16 other products in FDA’s Potassium Salt class priced per EA, 5 have a higher middle NADAC price and 11 a lower one. The one in the middle is POTASSIUM CL ER 20 MEQ TABLET, at $0.14078 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.